Description

CJC-1295 with DAC – 10mg

CJC-1295 with DAC (Drug Affinity Complex) is a long-acting GHRH analog studied for its ability to increase growth hormone (GH) and IGF-1 secretion in a controlled and sustained manner. The DAC component extends the peptide’s half-life significantly, allowing for more stable GH pulsatility over time compared to non-DAC variants.

In preclinical research, CJC-1295 with DAC has been evaluated for its potential role in promoting lean mass development, enhancing recovery, improving sleep quality, and supporting anti-aging and regenerative models.

---

Mechanism of Action (Based on Preclinical Research):

• Stimulates the pituitary to increase endogenous growth hormone (GH) release

• Prolonged half-life (~6–8 days) due to DAC, allowing for infrequent dosing

• Indirectly elevates IGF-1 levels, supporting anabolic and regenerative processes

---

Potential Benefits (Based on Preclinical Research):

• Increased GH and IGF-1 levels over extended periods

• Improved recovery and tissue repair

• Support for lean muscle development and fat metabolism

• May enhance sleep quality and immune response

---

⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.